Profiles of Generative AI Experts in US Pharmaceuticals
Profiles of leading US researchers and industry pioneers applying generative AI to pharmaceutical R&D, drug discovery, protein design, and clinical trials – updated with 2025-2026 milestones including Phase II/III results, major funding rounds, and regulatory breakthroughs.